Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 8.07259178 |
2 | cardiac myofibril assembly (GO:0055003) | 7.07729869 |
3 | actin-myosin filament sliding (GO:0033275) | 7.01273720 |
4 | muscle filament sliding (GO:0030049) | 7.01273720 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.76087928 |
6 | myofibril assembly (GO:0030239) | 6.64323580 |
7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.42795799 |
8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.27033570 |
9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.22356000 |
10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.16627402 |
11 | regulation of skeletal muscle contraction (GO:0014819) | 5.94762102 |
12 | actin-mediated cell contraction (GO:0070252) | 5.92367960 |
13 | plasma membrane repair (GO:0001778) | 5.88790074 |
14 | cardiac muscle contraction (GO:0060048) | 5.81468013 |
15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.69679006 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.48670803 |
17 | actomyosin structure organization (GO:0031032) | 5.42648069 |
18 | cardiac muscle cell development (GO:0055013) | 5.22291805 |
19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.17509310 |
20 | regulation of relaxation of muscle (GO:1901077) | 5.07257165 |
21 | striated muscle contraction (GO:0006941) | 5.01349335 |
22 | regulation of actin filament-based movement (GO:1903115) | 4.92940945 |
23 | cardiac cell development (GO:0055006) | 4.91415036 |
24 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.89733572 |
25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.87672623 |
26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.85836874 |
27 | regulation of cell communication by electrical coupling (GO:0010649) | 4.82105017 |
28 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.70874812 |
29 | cardiac muscle hypertrophy (GO:0003300) | 4.69381812 |
30 | actin filament-based movement (GO:0030048) | 4.65484737 |
31 | cell communication involved in cardiac conduction (GO:0086065) | 4.51461601 |
32 | adult heart development (GO:0007512) | 4.50735586 |
33 | striated muscle hypertrophy (GO:0014897) | 4.49146914 |
34 | regulation of sarcomere organization (GO:0060297) | 4.45795334 |
35 | regulation of membrane repolarization (GO:0060306) | 4.44459022 |
36 | regulation of striated muscle contraction (GO:0006942) | 4.42224528 |
37 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.41250173 |
38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.39154706 |
39 | tricarboxylic acid cycle (GO:0006099) | 4.36437385 |
40 | muscle tissue morphogenesis (GO:0060415) | 4.32192214 |
41 | cell communication by electrical coupling (GO:0010644) | 4.31375494 |
42 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.28922815 |
43 | heart process (GO:0003015) | 4.28419909 |
44 | heart contraction (GO:0060047) | 4.28419909 |
45 | detection of calcium ion (GO:0005513) | 4.26735441 |
46 | cardiac chamber formation (GO:0003207) | 4.26644773 |
47 | carnitine shuttle (GO:0006853) | 4.24457869 |
48 | adrenergic receptor signaling pathway (GO:0071875) | 4.14027684 |
49 | heart trabecula formation (GO:0060347) | 4.09730815 |
50 | skeletal muscle contraction (GO:0003009) | 3.98657813 |
51 | regulation of the force of heart contraction (GO:0002026) | 3.97592722 |
52 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.89590288 |
53 | muscle hypertrophy (GO:0014896) | 3.88077503 |
54 | response to muscle activity (GO:0014850) | 3.87834464 |
55 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.80090852 |
56 | response to inactivity (GO:0014854) | 3.77947856 |
57 | response to caffeine (GO:0031000) | 3.77338011 |
58 | cardiac muscle cell action potential (GO:0086001) | 3.76202486 |
59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.70830236 |
60 | regulation of cardiac muscle contraction (GO:0055117) | 3.67377956 |
61 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.65886175 |
62 | relaxation of cardiac muscle (GO:0055119) | 3.65449873 |
63 | negative regulation of potassium ion transport (GO:0043267) | 3.65038205 |
64 | relaxation of muscle (GO:0090075) | 3.64757419 |
65 | fatty acid transmembrane transport (GO:1902001) | 3.62990618 |
66 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.58737979 |
67 | muscle contraction (GO:0006936) | 3.57895069 |
68 | cardiac ventricle formation (GO:0003211) | 3.57804391 |
69 | regulation of heart rate (GO:0002027) | 3.52342018 |
70 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.51551527 |
71 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.51551527 |
72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50956015 |
73 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.43928207 |
74 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.43768012 |
75 | cardiac conduction (GO:0061337) | 3.42662733 |
76 | striated muscle cell development (GO:0055002) | 3.38359813 |
77 | muscle system process (GO:0003012) | 3.33193008 |
78 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.31867535 |
79 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.30829621 |
80 | regulation of heart contraction (GO:0008016) | 3.30782728 |
81 | positive regulation of cation channel activity (GO:2001259) | 3.30768431 |
82 | negative regulation of protein localization to cell surface (GO:2000009) | 3.28859789 |
83 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.24213221 |
84 | otic vesicle formation (GO:0030916) | 3.20479222 |
85 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.17745009 |
86 | muscle fiber development (GO:0048747) | 3.16113134 |
87 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.14128024 |
88 | positive regulation of myoblast differentiation (GO:0045663) | 3.10364436 |
89 | regulation of muscle contraction (GO:0006937) | 3.10018580 |
90 | growth hormone secretion (GO:0030252) | 3.09671979 |
91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.09565644 |
92 | muscle hypertrophy in response to stress (GO:0003299) | 3.09565644 |
93 | cardiac muscle adaptation (GO:0014887) | 3.09565644 |
94 | response to epinephrine (GO:0071871) | 3.07997183 |
95 | regulation of cofactor metabolic process (GO:0051193) | 3.06966554 |
96 | regulation of coenzyme metabolic process (GO:0051196) | 3.06966554 |
97 | positive regulation of heart rate (GO:0010460) | 3.06498920 |
98 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.06035447 |
99 | regulation of cardioblast proliferation (GO:0003264) | 3.06035447 |
100 | striated muscle adaptation (GO:0014888) | 3.05232475 |
101 | cardiac septum development (GO:0003279) | 3.02256125 |
102 | regulation of ATPase activity (GO:0043462) | 3.01891642 |
103 | regulation of ATP catabolic process (GO:1903289) | 3.01891642 |
104 | muscle cell cellular homeostasis (GO:0046716) | 2.99954490 |
105 | carnitine transmembrane transport (GO:1902603) | 2.99909670 |
106 | creatine metabolic process (GO:0006600) | 2.98490854 |
107 | skeletal muscle adaptation (GO:0043501) | 2.97474002 |
108 | myotube cell development (GO:0014904) | 2.96627374 |
109 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.96057576 |
110 | regulation of muscle system process (GO:0090257) | 2.95074924 |
111 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.93903931 |
112 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.93903931 |
113 | muscle cell development (GO:0055001) | 2.91837777 |
114 | positive regulation of heart contraction (GO:0045823) | 2.91784553 |
115 | regulation of myoblast differentiation (GO:0045661) | 2.90890088 |
116 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89034963 |
117 | skeletal muscle tissue development (GO:0007519) | 2.87796523 |
118 | regulation of cardioblast differentiation (GO:0051890) | 2.87678231 |
119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.85803908 |
120 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84495131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.77614377 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08609534 |
3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.87332437 |
4 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.82012463 |
5 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.82012463 |
6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.54311385 |
7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53843514 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51650602 |
9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40228981 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.35395912 |
11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.27473801 |
12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.23114192 |
13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.19218611 |
14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18811592 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15946602 |
16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13441677 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11674119 |
18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.99765021 |
19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99499080 |
20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.96282328 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90445726 |
22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.89432666 |
23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75389852 |
24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75136621 |
25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.73293098 |
26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69801536 |
27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69801536 |
28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69508356 |
29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69454729 |
30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68769224 |
31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67752961 |
32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67623029 |
33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.67456220 |
34 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.65955412 |
35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62556753 |
36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.61187564 |
37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59426779 |
38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58368000 |
39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58274446 |
40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56025227 |
41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55549106 |
42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55091881 |
43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53997540 |
44 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.51523222 |
45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51068354 |
46 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51061597 |
47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49695997 |
48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45409295 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45165177 |
50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44785810 |
51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43671611 |
52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42928303 |
53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40281859 |
54 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39990735 |
55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.37244210 |
56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37099223 |
57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36118502 |
58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35388604 |
59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34350687 |
60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34283568 |
61 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.32542212 |
62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32362792 |
63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32117605 |
64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31568703 |
65 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.30905104 |
66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30461378 |
67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30272771 |
68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29326189 |
69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28692098 |
70 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28582486 |
71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28197752 |
72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27897221 |
73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26086365 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26080128 |
75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25838266 |
76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25252487 |
77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24661439 |
78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23220524 |
79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22353648 |
80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22151315 |
81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22033907 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20755539 |
83 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20654046 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19134904 |
85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18462759 |
86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18462759 |
87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18145966 |
88 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.18103651 |
89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17928372 |
90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17928372 |
91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17540388 |
92 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16798196 |
93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16654059 |
94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15601329 |
95 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14036445 |
96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13311109 |
97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12687094 |
98 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12546059 |
99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12477963 |
100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12073611 |
101 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11806300 |
102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11145358 |
103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10406248 |
104 | TBL1_22424771_ChIP-Seq_293T_Human | 1.10217946 |
105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09575076 |
106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09275325 |
107 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09073153 |
108 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08831832 |
109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08828660 |
110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08736548 |
111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08343996 |
112 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07948456 |
113 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07948456 |
114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07518832 |
115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06774143 |
116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06774143 |
117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06471436 |
118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04724740 |
119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04458684 |
120 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04106616 |
121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03850269 |
122 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02983163 |
123 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02652980 |
124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02195513 |
125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02010704 |
126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01810670 |
127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01663782 |
128 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01504872 |
129 | AR_19668381_ChIP-Seq_PC3_Human | 1.00418430 |
130 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99900238 |
131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99766780 |
132 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99670640 |
133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98786355 |
134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98336420 |
135 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97837250 |
136 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.97345428 |
137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95147552 |
138 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94423113 |
139 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93100779 |
140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92732014 |
141 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91733609 |
142 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91683759 |
143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91013757 |
144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90319252 |
145 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89460089 |
146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89223181 |
147 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88981784 |
148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88688336 |
149 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87509526 |
150 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85966310 |
151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84002495 |
152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83835957 |
153 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83709506 |
154 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83433745 |
155 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83338248 |
156 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82402238 |
157 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81505392 |
158 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81454349 |
159 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81228681 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.30922381 |
2 | MP0000751_myopathy | 5.30654007 |
3 | MP0004084_abnormal_cardiac_muscle | 5.03887938 |
4 | MP0003646_muscle_fatigue | 4.65449802 |
5 | MP0004215_abnormal_myocardial_fiber | 4.28350965 |
6 | MP0000749_muscle_degeneration | 4.20072338 |
7 | MP0004036_abnormal_muscle_relaxation | 4.06436223 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.67923753 |
9 | MP0005330_cardiomyopathy | 3.45657829 |
10 | MP0004087_abnormal_muscle_fiber | 3.04773550 |
11 | MP0002972_abnormal_cardiac_muscle | 2.85479732 |
12 | MP0000750_abnormal_muscle_regeneration | 2.82375147 |
13 | MP0005620_abnormal_muscle_contractility | 2.77341277 |
14 | MP0002106_abnormal_muscle_physiology | 2.67251917 |
15 | MP0003137_abnormal_impulse_conducting | 2.49414245 |
16 | MP0008775_abnormal_heart_ventricle | 2.44943173 |
17 | MP0002269_muscular_atrophy | 2.40631213 |
18 | MP0000747_muscle_weakness | 2.33929525 |
19 | MP0010630_abnormal_cardiac_muscle | 2.27486118 |
20 | MP0004130_abnormal_muscle_cell | 2.24519101 |
21 | MP0000759_abnormal_skeletal_muscle | 2.24194122 |
22 | MP0004484_altered_response_of | 2.23469771 |
23 | MP0005369_muscle_phenotype | 2.23462447 |
24 | MP0005385_cardiovascular_system_phenoty | 2.20388754 |
25 | MP0001544_abnormal_cardiovascular_syste | 2.20388754 |
26 | MP0004085_abnormal_heartbeat | 2.05908457 |
27 | MP0006138_congestive_heart_failure | 1.99314388 |
28 | MP0003828_pulmonary_edema | 1.87368421 |
29 | MP0004510_myositis | 1.84604014 |
30 | MP0003950_abnormal_plasma_membrane | 1.81777615 |
31 | MP0002127_abnormal_cardiovascular_syste | 1.74784552 |
32 | MP0004233_abnormal_muscle_weight | 1.73681360 |
33 | MP0009780_abnormal_chondrocyte_physiolo | 1.66957736 |
34 | MP0000013_abnormal_adipose_tissue | 1.63841969 |
35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.54699992 |
36 | MP0010368_abnormal_lymphatic_system | 1.50330127 |
37 | MP0002909_abnormal_adrenal_gland | 1.38341123 |
38 | MP0005670_abnormal_white_adipose | 1.32965340 |
39 | MP0001879_abnormal_lymphatic_vessel | 1.27241775 |
40 | MP0002332_abnormal_exercise_endurance | 1.27015028 |
41 | MP0002108_abnormal_muscle_morphology | 1.24283188 |
42 | MP0003045_fibrosis | 1.16965956 |
43 | MP0006036_abnormal_mitochondrial_physio | 1.16892278 |
44 | MP0003136_yellow_coat_color | 1.14958871 |
45 | MP0005666_abnormal_adipose_tissue | 1.11992365 |
46 | MP0002822_catalepsy | 1.08778277 |
47 | MP0004272_abnormal_basement_membrane | 1.06915509 |
48 | MP0000266_abnormal_heart_morphology | 1.03667820 |
49 | MP0002234_abnormal_pharynx_morphology | 1.03453229 |
50 | MP0000733_abnormal_muscle_development | 1.02400413 |
51 | MP0004270_analgesia | 0.96208858 |
52 | MP0002102_abnormal_ear_morphology | 0.96106763 |
53 | MP0003279_aneurysm | 0.93581328 |
54 | MP0005623_abnormal_meninges_morphology | 0.93477963 |
55 | MP0005375_adipose_tissue_phenotype | 0.92134258 |
56 | MP0000230_abnormal_systemic_arterial | 0.91277960 |
57 | MP0002638_abnormal_pupillary_reflex | 0.87785261 |
58 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87063094 |
59 | MP0000003_abnormal_adipose_tissue | 0.83718436 |
60 | MP0005165_increased_susceptibility_to | 0.81033596 |
61 | MP0004043_abnormal_pH_regulation | 0.79209477 |
62 | MP0004185_abnormal_adipocyte_glucose | 0.77582708 |
63 | MP0001984_abnormal_olfaction | 0.77351044 |
64 | MP0002877_abnormal_melanocyte_morpholog | 0.75888741 |
65 | MP0003283_abnormal_digestive_organ | 0.74366294 |
66 | MP0008961_abnormal_basal_metabolism | 0.71145887 |
67 | MP0002128_abnormal_blood_circulation | 0.70699549 |
68 | MP0003937_abnormal_limbs/digits/tail_de | 0.67563801 |
69 | MP0006292_abnormal_olfactory_placode | 0.67146839 |
70 | MP0002078_abnormal_glucose_homeostasis | 0.66632085 |
71 | MP0000343_altered_response_to | 0.63864000 |
72 | MP0000767_abnormal_smooth_muscle | 0.63004175 |
73 | MP0005187_abnormal_penis_morphology | 0.61678269 |
74 | MP0001485_abnormal_pinna_reflex | 0.60901941 |
75 | MP0005167_abnormal_blood-brain_barrier | 0.59952631 |
76 | MP0004859_abnormal_synaptic_plasticity | 0.58233796 |
77 | MP0009250_abnormal_appendicular_skeleto | 0.57960274 |
78 | MP0010030_abnormal_orbit_morphology | 0.57626159 |
79 | MP0004133_heterotaxia | 0.56958399 |
80 | MP0001270_distended_abdomen | 0.56912364 |
81 | MP0003566_abnormal_cell_adhesion | 0.55847812 |
82 | MP0004142_abnormal_muscle_tone | 0.55198482 |
83 | MP0005266_abnormal_metabolism | 0.55109235 |
84 | MP0005248_abnormal_Harderian_gland | 0.54967698 |
85 | MP0009384_cardiac_valve_regurgitation | 0.54756964 |
86 | MP0000462_abnormal_digestive_system | 0.53997889 |
87 | MP0003119_abnormal_digestive_system | 0.53662927 |
88 | MP0002925_abnormal_cardiovascular_devel | 0.51418504 |
89 | MP0004885_abnormal_endolymph | 0.51397705 |
90 | MP0005253_abnormal_eye_physiology | 0.51322740 |
91 | MP0001486_abnormal_startle_reflex | 0.50700103 |
92 | MP0005646_abnormal_pituitary_gland | 0.49647335 |
93 | MP0003122_maternal_imprinting | 0.47104206 |
94 | MP0000372_irregular_coat_pigmentation | 0.46721961 |
95 | MP0002896_abnormal_bone_mineralization | 0.43823564 |
96 | MP0005595_abnormal_vascular_smooth | 0.43391306 |
97 | MP0002971_abnormal_brown_adipose | 0.43252379 |
98 | MP0001299_abnormal_eye_distance/ | 0.42703669 |
99 | MP0002693_abnormal_pancreas_physiology | 0.41951007 |
100 | MP0006072_abnormal_retinal_apoptosis | 0.41867826 |
101 | MP0000049_abnormal_middle_ear | 0.41801390 |
102 | MP0005386_behavior/neurological_phenoty | 0.41430697 |
103 | MP0004924_abnormal_behavior | 0.41430697 |
104 | MP0005551_abnormal_eye_electrophysiolog | 0.41339633 |
105 | MP0003941_abnormal_skin_development | 0.40682097 |
106 | MP0000631_abnormal_neuroendocrine_gland | 0.39674466 |
107 | MP0000026_abnormal_inner_ear | 0.39370301 |
108 | MP0003705_abnormal_hypodermis_morpholog | 0.38284905 |
109 | MP0004147_increased_porphyrin_level | 0.37788988 |
110 | MP0006035_abnormal_mitochondrial_morpho | 0.37715224 |
111 | MP0003385_abnormal_body_wall | 0.36855021 |
112 | MP0005535_abnormal_body_temperature | 0.36524435 |
113 | MP0002272_abnormal_nervous_system | 0.36506462 |
114 | MP0001784_abnormal_fluid_regulation | 0.35820136 |
115 | MP0000534_abnormal_ureter_morphology | 0.35728291 |
116 | MP0001614_abnormal_blood_vessel | 0.35173748 |
117 | MP0003948_abnormal_gas_homeostasis | 0.34727694 |
118 | MP0008569_lethality_at_weaning | 0.33763056 |
119 | MP0000537_abnormal_urethra_morphology | 0.33399991 |
120 | MP0002734_abnormal_mechanical_nocicepti | 0.32268284 |
121 | MP0001293_anophthalmia | 0.32111969 |
122 | MP0008438_abnormal_cutaneous_collagen | 0.32076056 |
123 | MP0002249_abnormal_larynx_morphology | 0.30560430 |
124 | MP0003935_abnormal_craniofacial_develop | 0.29893518 |
125 | MP0001661_extended_life_span | 0.29177946 |
126 | MP0006276_abnormal_autonomic_nervous | 0.28960325 |
127 | MP0001727_abnormal_embryo_implantation | 0.28913914 |
128 | MP0005334_abnormal_fat_pad | 0.26854002 |
129 | MP0004858_abnormal_nervous_system | 0.26128379 |
130 | MP0003953_abnormal_hormone_level | 0.25600234 |
131 | MP0001765_abnormal_ion_homeostasis | 0.25068219 |
132 | MP0002168_other_aberrant_phenotype | 0.24908784 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.62882324 |
2 | Calf muscle hypertrophy (HP:0008981) | 6.20274927 |
3 | Exercise-induced myalgia (HP:0003738) | 6.09761343 |
4 | Muscle fiber splitting (HP:0003555) | 5.92466725 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.83006836 |
6 | Ventricular tachycardia (HP:0004756) | 5.74882776 |
7 | Exercise-induced muscle cramps (HP:0003710) | 5.52446883 |
8 | Abnormality of the calf musculature (HP:0001430) | 5.37452187 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 5.35016941 |
10 | Atrial fibrillation (HP:0005110) | 5.33410394 |
11 | Primary atrial arrhythmia (HP:0001692) | 5.00435651 |
12 | Supraventricular tachycardia (HP:0004755) | 4.79861923 |
13 | Supraventricular arrhythmia (HP:0005115) | 4.72845695 |
14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.70769122 |
15 | Subaortic stenosis (HP:0001682) | 4.70769122 |
16 | Lipoatrophy (HP:0100578) | 4.63338046 |
17 | Syncope (HP:0001279) | 4.45759061 |
18 | EMG: myopathic abnormalities (HP:0003458) | 4.44962510 |
19 | Myoglobinuria (HP:0002913) | 4.38000720 |
20 | Right ventricular cardiomyopathy (HP:0011663) | 4.33454264 |
21 | Prolonged QT interval (HP:0001657) | 4.29911099 |
22 | Difficulty running (HP:0009046) | 4.16816926 |
23 | Bundle branch block (HP:0011710) | 4.15051294 |
24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.07902298 |
25 | Type 1 muscle fiber predominance (HP:0003803) | 4.07031094 |
26 | Increased connective tissue (HP:0009025) | 4.06002891 |
27 | Muscle fiber inclusion bodies (HP:0100299) | 4.05368215 |
28 | Dilated cardiomyopathy (HP:0001644) | 3.92422486 |
29 | Ventricular arrhythmia (HP:0004308) | 3.68657633 |
30 | Asymmetric septal hypertrophy (HP:0001670) | 3.62812658 |
31 | Myotonia (HP:0002486) | 3.57976549 |
32 | Palpitations (HP:0001962) | 3.55334568 |
33 | Heart block (HP:0012722) | 3.40764627 |
34 | Nemaline bodies (HP:0003798) | 3.31449524 |
35 | Ventricular fibrillation (HP:0001663) | 3.29230748 |
36 | Abnormal atrioventricular conduction (HP:0005150) | 3.22849293 |
37 | Difficulty climbing stairs (HP:0003551) | 3.21105914 |
38 | Atrioventricular block (HP:0001678) | 3.18928471 |
39 | Abnormal EKG (HP:0003115) | 3.13972525 |
40 | Rhabdomyolysis (HP:0003201) | 3.06858370 |
41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.00978549 |
42 | Absent phalangeal crease (HP:0006109) | 2.87093301 |
43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.82601268 |
44 | Neck muscle weakness (HP:0000467) | 2.80154003 |
45 | Distal arthrogryposis (HP:0005684) | 2.68102558 |
46 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.65017851 |
47 | Left ventricular hypertrophy (HP:0001712) | 2.63276612 |
48 | Ketoacidosis (HP:0001993) | 2.62882892 |
49 | Hypoglycemic coma (HP:0001325) | 2.59121681 |
50 | Areflexia of lower limbs (HP:0002522) | 2.52277292 |
51 | Hypoplastic ischia (HP:0003175) | 2.48671118 |
52 | Myopathic facies (HP:0002058) | 2.46392358 |
53 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45897316 |
54 | EMG: neuropathic changes (HP:0003445) | 2.45214136 |
55 | Gowers sign (HP:0003391) | 2.44761262 |
56 | Muscle stiffness (HP:0003552) | 2.44390080 |
57 | Round ear (HP:0100830) | 2.39523285 |
58 | Rimmed vacuoles (HP:0003805) | 2.37343713 |
59 | Limited hip movement (HP:0008800) | 2.35950349 |
60 | Muscular dystrophy (HP:0003560) | 2.35783886 |
61 | Pheochromocytoma (HP:0002666) | 2.35094061 |
62 | Abnormal finger flexion creases (HP:0006143) | 2.30108683 |
63 | Deformed tarsal bones (HP:0008119) | 2.28792195 |
64 | Abnormality of the foot musculature (HP:0001436) | 2.28543207 |
65 | Distal lower limb muscle weakness (HP:0009053) | 2.26410121 |
66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25675277 |
67 | Malignant hyperthermia (HP:0002047) | 2.23995846 |
68 | Abnormality of the ischium (HP:0003174) | 2.22989222 |
69 | Distal lower limb amyotrophy (HP:0008944) | 2.21963111 |
70 | Facial diplegia (HP:0001349) | 2.21179062 |
71 | Foot dorsiflexor weakness (HP:0009027) | 2.20956411 |
72 | Limb-girdle muscle atrophy (HP:0003797) | 2.13010662 |
73 | Palmoplantar keratoderma (HP:0000982) | 2.12931785 |
74 | Scapular winging (HP:0003691) | 2.08686614 |
75 | Calcaneovalgus deformity (HP:0001848) | 2.07195513 |
76 | Proximal amyotrophy (HP:0007126) | 2.06489901 |
77 | Large for gestational age (HP:0001520) | 2.03303236 |
78 | Generalized muscle weakness (HP:0003324) | 2.02896773 |
79 | Neuroendocrine neoplasm (HP:0100634) | 2.02468608 |
80 | Fetal akinesia sequence (HP:0001989) | 2.01568643 |
81 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.00773598 |
82 | Testicular atrophy (HP:0000029) | 2.00531291 |
83 | Hyperglycemia (HP:0003074) | 1.97723445 |
84 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96212311 |
85 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93165557 |
86 | Maternal diabetes (HP:0009800) | 1.92631871 |
87 | Hip contracture (HP:0003273) | 1.88535137 |
88 | Fatigable weakness (HP:0003473) | 1.88350646 |
89 | Abnormality of the neuromuscular junction (HP:0003398) | 1.88350646 |
90 | Hamartoma of the eye (HP:0010568) | 1.87500770 |
91 | Sudden cardiac death (HP:0001645) | 1.87371534 |
92 | Ulnar deviation of the wrist (HP:0003049) | 1.86095165 |
93 | Waddling gait (HP:0002515) | 1.85161374 |
94 | Lower limb amyotrophy (HP:0007210) | 1.84393676 |
95 | Congenital malformation of the right heart (HP:0011723) | 1.82949622 |
96 | Double outlet right ventricle (HP:0001719) | 1.82949622 |
97 | Diaphragmatic weakness (HP:0009113) | 1.81358874 |
98 | Spinal rigidity (HP:0003306) | 1.81130405 |
99 | Frequent falls (HP:0002359) | 1.80732210 |
100 | Congestive heart failure (HP:0001635) | 1.80483856 |
101 | Toxemia of pregnancy (HP:0100603) | 1.76312660 |
102 | Weak cry (HP:0001612) | 1.76269584 |
103 | Steppage gait (HP:0003376) | 1.75585156 |
104 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74384879 |
105 | Dysmetric saccades (HP:0000641) | 1.73024727 |
106 | Neoplasm of the adrenal gland (HP:0100631) | 1.72116252 |
107 | Hypoglycemic seizures (HP:0002173) | 1.65960498 |
108 | Hyperkalemia (HP:0002153) | 1.65580804 |
109 | Periauricular skin pits (HP:0100277) | 1.64897434 |
110 | Preauricular pit (HP:0004467) | 1.64897434 |
111 | Ragged-red muscle fibers (HP:0003200) | 1.63909890 |
112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.63684382 |
113 | Ketosis (HP:0001946) | 1.62108798 |
114 | Lymphangioma (HP:0100764) | 1.61941220 |
115 | Bulbar palsy (HP:0001283) | 1.61892204 |
116 | Acute necrotizing encephalopathy (HP:0006965) | 1.59106270 |
117 | Dicarboxylic aciduria (HP:0003215) | 1.58212807 |
118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.58212807 |
119 | Easy fatigability (HP:0003388) | 1.56852754 |
120 | Hypoplastic heart (HP:0001961) | 1.56343785 |
121 | Popliteal pterygium (HP:0009756) | 1.55983021 |
122 | Ulnar deviation of finger (HP:0009465) | 1.51209716 |
123 | Aplasia of the musculature (HP:0100854) | 1.48473355 |
124 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.47063381 |
125 | Bradycardia (HP:0001662) | 1.46202949 |
126 | Nephronophthisis (HP:0000090) | 1.46130106 |
127 | Tubular atrophy (HP:0000092) | 1.45729995 |
128 | Long clavicles (HP:0000890) | 1.42658137 |
129 | Abnormality of the renal cortex (HP:0011035) | 1.42628899 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 5.91039124 |
2 | TTN | 4.59527979 |
3 | PHKG2 | 3.66611671 |
4 | PHKG1 | 3.66611671 |
5 | DMPK | 3.14347805 |
6 | LMTK2 | 3.06248428 |
7 | MYLK | 3.03342130 |
8 | INSRR | 2.83400983 |
9 | MUSK | 2.79149768 |
10 | TIE1 | 2.41464151 |
11 | PDK4 | 2.36685249 |
12 | PDK3 | 2.36685249 |
13 | TRIB3 | 2.28305537 |
14 | NEK1 | 1.95474402 |
15 | PRKD3 | 1.91318754 |
16 | PIK3CA | 1.90047109 |
17 | PKN2 | 1.83274506 |
18 | ZAK | 1.66303853 |
19 | STK39 | 1.64391937 |
20 | FRK | 1.63735504 |
21 | EPHB2 | 1.57649575 |
22 | PINK1 | 1.51011224 |
23 | PDK2 | 1.48071862 |
24 | PIK3CG | 1.45504010 |
25 | CDC42BPA | 1.43627300 |
26 | STK24 | 1.36867740 |
27 | PAK3 | 1.23437107 |
28 | MARK1 | 1.21968545 |
29 | PRKD1 | 1.20538881 |
30 | TNIK | 1.18109470 |
31 | CAMK2D | 1.15981554 |
32 | ROCK1 | 1.10120520 |
33 | BCKDK | 1.05799671 |
34 | NEK9 | 1.02925662 |
35 | WNK4 | 1.02550504 |
36 | RIPK1 | 1.00975383 |
37 | ILK | 1.00754585 |
38 | MAP3K7 | 0.98890738 |
39 | PRKAA1 | 0.98377928 |
40 | BMPR1B | 0.95381110 |
41 | NLK | 0.92094487 |
42 | GRK7 | 0.91754652 |
43 | MAPK12 | 0.89298854 |
44 | EPHA4 | 0.85889013 |
45 | PRKAA2 | 0.84566744 |
46 | PTK2B | 0.82748703 |
47 | PDGFRA | 0.82522033 |
48 | GRK1 | 0.81264544 |
49 | NTRK3 | 0.79050606 |
50 | NME1 | 0.78513473 |
51 | KDR | 0.78142484 |
52 | MAPKAPK3 | 0.72316179 |
53 | EPHA3 | 0.72263117 |
54 | TRPM7 | 0.69296399 |
55 | STK38 | 0.69012770 |
56 | LIMK1 | 0.68479805 |
57 | PRKCH | 0.68404151 |
58 | STK38L | 0.68062212 |
59 | WNK1 | 0.67771976 |
60 | MAP3K10 | 0.67681556 |
61 | EPHB1 | 0.67507984 |
62 | MAP3K3 | 0.66675843 |
63 | FER | 0.64366128 |
64 | KSR1 | 0.63270406 |
65 | CAMK4 | 0.62213493 |
66 | RPS6KA2 | 0.60783436 |
67 | CAMK2A | 0.60707554 |
68 | MARK2 | 0.58211924 |
69 | MAP3K5 | 0.57716063 |
70 | NEK6 | 0.56649648 |
71 | PKN1 | 0.56567304 |
72 | PTK6 | 0.56004804 |
73 | MAP2K3 | 0.52371289 |
74 | MAPK7 | 0.51711003 |
75 | CAMK1 | 0.51500267 |
76 | MAP4K2 | 0.51139983 |
77 | TGFBR2 | 0.50371204 |
78 | ADRBK1 | 0.50104561 |
79 | MAPK13 | 0.49797594 |
80 | ADRBK2 | 0.49552772 |
81 | PRKACB | 0.49279475 |
82 | PRKCE | 0.48348316 |
83 | UHMK1 | 0.47335123 |
84 | KSR2 | 0.45780573 |
85 | PLK2 | 0.45703013 |
86 | STK3 | 0.45388604 |
87 | MAP3K1 | 0.44403646 |
88 | PRKACA | 0.43143858 |
89 | MAPK15 | 0.43133864 |
90 | DAPK3 | 0.42956812 |
91 | PRKACG | 0.42312878 |
92 | WNK3 | 0.41815806 |
93 | STK11 | 0.41452973 |
94 | HIPK2 | 0.41061097 |
95 | CAMK2B | 0.40965452 |
96 | SGK1 | 0.40898980 |
97 | MAPK4 | 0.40363282 |
98 | ERBB3 | 0.40221657 |
99 | SGK494 | 0.40151075 |
100 | SGK223 | 0.40151075 |
101 | SGK3 | 0.39453643 |
102 | RET | 0.39378623 |
103 | PNCK | 0.38839500 |
104 | AKT2 | 0.38703316 |
105 | RPS6KL1 | 0.37819601 |
106 | RPS6KC1 | 0.37819601 |
107 | PDPK1 | 0.37746286 |
108 | AKT3 | 0.37002448 |
109 | TGFBR1 | 0.36780865 |
110 | SIK1 | 0.36659641 |
111 | PRKG2 | 0.36018477 |
112 | ROCK2 | 0.35499142 |
113 | BRSK2 | 0.35166685 |
114 | MAP2K1 | 0.33014435 |
115 | LATS1 | 0.32090702 |
116 | SGK2 | 0.32007878 |
117 | ACVR1B | 0.31583626 |
118 | PRKG1 | 0.31416594 |
119 | NUAK1 | 0.31326049 |
120 | RPS6KA3 | 0.31320973 |
121 | FLT3 | 0.30888507 |
122 | CAMK2G | 0.30408479 |
123 | MAP3K2 | 0.30352614 |
124 | CAMK1G | 0.30321162 |
125 | DYRK2 | 0.29607513 |
126 | PDK1 | 0.29531953 |
127 | PAK6 | 0.29060370 |
128 | FGFR2 | 0.28615950 |
129 | PRKCQ | 0.28278020 |
130 | FGFR1 | 0.28178822 |
131 | MAP3K4 | 0.27198516 |
132 | NTRK1 | 0.26122817 |
133 | MTOR | 0.25966881 |
134 | CCNB1 | 0.25892284 |
135 | MAP2K4 | 0.25660672 |
136 | MARK3 | 0.24635915 |
137 | LATS2 | 0.23758536 |
138 | DYRK1B | 0.20769446 |
139 | MOS | 0.20254288 |
140 | RPS6KA1 | 0.18793065 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.55363487 |
2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.06160114 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.98583183 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.87181208 |
5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.02284838 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.65721596 |
7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.26606682 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07248268 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02409671 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01624642 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78480627 |
12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71251035 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66847252 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.65795474 |
15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.57041490 |
16 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.53829004 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41455777 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39862062 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39433877 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37283585 |
21 | Insulin resistance_Homo sapiens_hsa04931 | 1.37241656 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36647910 |
23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.36376877 |
24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27377431 |
25 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.23464652 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19404595 |
27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18541131 |
28 | Focal adhesion_Homo sapiens_hsa04510 | 1.18405339 |
29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17590701 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.14752426 |
31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.11433661 |
32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07724862 |
33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.05570538 |
34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04328623 |
35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02666672 |
36 | Phototransduction_Homo sapiens_hsa04744 | 0.98814509 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98809689 |
38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97600594 |
39 | Tight junction_Homo sapiens_hsa04530 | 0.97474555 |
40 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97223609 |
41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95553018 |
42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94532171 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94143379 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93539911 |
45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91814902 |
46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90547251 |
47 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89898671 |
48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89483154 |
49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89372211 |
50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88373937 |
51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87382150 |
52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87372738 |
53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85395558 |
54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82626123 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80228310 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79520608 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77585140 |
58 | Adherens junction_Homo sapiens_hsa04520 | 0.76750007 |
59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75719234 |
60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75451737 |
61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73792385 |
62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72617916 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.71600082 |
64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71576464 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71433803 |
66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70302593 |
67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69015629 |
68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68982084 |
69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68593624 |
70 | Gap junction_Homo sapiens_hsa04540 | 0.67673907 |
71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67647195 |
72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67327652 |
73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66466667 |
74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65348608 |
75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63911127 |
76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62703258 |
77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62546862 |
78 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62377972 |
79 | Taste transduction_Homo sapiens_hsa04742 | 0.61649926 |
80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61167489 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.59863255 |
82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59374145 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58965602 |
84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57223754 |
85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54852513 |
86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54813124 |
87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54662163 |
88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54017695 |
89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53950504 |
90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53584736 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.53403436 |
92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.51747380 |
93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51165040 |
94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50459140 |
95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50181315 |
96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49313633 |
97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47934385 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46424342 |
99 | Amoebiasis_Homo sapiens_hsa05146 | 0.46393379 |
100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46344130 |
101 | ABC transporters_Homo sapiens_hsa02010 | 0.45671183 |
102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45431163 |
103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44868110 |
104 | Peroxisome_Homo sapiens_hsa04146 | 0.44661382 |
105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43621021 |
106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43605751 |
107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43376570 |
108 | Platelet activation_Homo sapiens_hsa04611 | 0.42670474 |
109 | Melanogenesis_Homo sapiens_hsa04916 | 0.42372945 |
110 | Mineral absorption_Homo sapiens_hsa04978 | 0.41799064 |
111 | RNA degradation_Homo sapiens_hsa03018 | 0.40995126 |
112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40579231 |
113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40386454 |
114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39874219 |
115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39735372 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39003912 |
117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38534164 |
118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37370776 |
119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36861722 |
120 | Axon guidance_Homo sapiens_hsa04360 | 0.36776864 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35752562 |
122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34892774 |
123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34745878 |
124 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33489450 |
125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33007302 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28266462 |
127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27889942 |
128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26335224 |
129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26086577 |
130 | Bile secretion_Homo sapiens_hsa04976 | 0.25989540 |